Skip to main navigation
TCR2 Staging

Corporate Menu & Investor Relations

Contact Patients
Mission Leadership Community
The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications
Overview TC-210 TC-110 Pipeline
Press Releases In the News Awards
Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs
Careers
investors.jpg
TCR2 Investors

Corporate Menu & Investor Relations

About Us Mission Leadership Community Technology The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications Programs Overview TC-210 TC-110 Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Contact Patients

Press Releases

Latest Press Releases | In The News

Press Releases

All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |

Dec 21, 2020

TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference


Dec 13, 2020

TCR² Announces RECIST Response in Ovarian Cancer from Ongoing Phase 1/2 Trial of TC-210 in Treatment Refractory Mesothelin-Expressing Solid Tumors


Dec 11, 2020

TCR² Therapeutics to Announce Interim Data from Phase 1/2 Clinical Trial of TC-210 in Mesothelin-Expressing Solid Tumors


Nov 12, 2020

TCR² Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update


Nov 10, 2020

TCR² Therapeutics Announces Partnership with ElevateBio to Expand TC-210 Manufacturing Capacity


Sep 29, 2020

TCR² Therapeutics to Present at Jefferies Cell Therapy Virtual Summit


Sep 08, 2020

TCR² Therapeutics to Participate in Two Upcoming Conferences in September


Aug 12, 2020

TCR² Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update


Aug 06, 2020

TCR² Therapeutics to Present at the Wedbush PacGrow Healthcare Conference


Jul 28, 2020

TCR² Therapeutics Announces Pricing of Public Offering of Common Stock


Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
TCR2
 

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

TERMS OF USE

Corporate Menu & Investor Relations

About Us
Technology
Programs
News
Investors
Careers
Contact
Patients